DOI QR코드

DOI QR Code

Treatment of non-odontogenic orofacial pain using botulinum toxin-A: a retrospective case series study

  • Kim, Sang-Yun (Department of Oral and Maxillofacial Surgery, Section of Dentistry, Seoul National University Bundang Hospital) ;
  • Kim, Young-Kyun (Department of Oral and Maxillofacial Surgery, Section of Dentistry, Seoul National University Bundang Hospital) ;
  • Yun, Pil-Young (Department of Oral and Maxillofacial Surgery, Section of Dentistry, Seoul National University Bundang Hospital) ;
  • Bae, Ji-Hyun (Department of Conservative Dentistry, Section of Dentistry, Seoul National University Bundang Hospital)
  • Received : 2018.06.17
  • Accepted : 2018.07.12
  • Published : 2018.12.31

Abstract

Background: The purpose of this study was to evaluate the clinical outcomes of treatment of non-odontogenic atypical orofacial pain using botulinum toxin-A. Methods: This study involved seven patients (seven females, mean age 65.1 years) who had non-odontogenic orofacial pain (neuropathic pain and atypical orofacial pain) and visited the Seoul National University Bundang Hospital between 2015 and 2017. All medication therapies were preceded by botulinum toxin-A injections, followed by injections in the insignificant effects of medication therapies. Five of the seven patients received intraoral injections in the gingival vestibule or mucosa, while the remaining two received extraoral injections in the masseter and temporal muscle areas. Results: In five of the seven patients, pain after botulinum toxin-A injection was significantly reduced. Most of the patients who underwent surgery for dental implantation or facial nerve reconstruction recovered after injections. However, the pain did not disappear in two patients who reported experiencing persistent pain without any cause. Conclusions: The use of botulinum toxin-A for the treatment of non-odontogenic neuropathic orofacial pain is clinically useful. It is more effective to administer botulinum toxin-A in combination with other medications and physical therapy to improve pain.

Keywords

References

  1. Dworkin SF, LeResche L (1992) Research diagnostic criteria for temporomandibular disorders: review, criteria, examination and specifications, critique. J Craniomandib Disord: Facial Oral Pain 6:301-355
  2. Kim HS, Yun PY, Kim YK (2016) A clinical evaluation of botulinum toxin-A injections in the temporomandibular disorder treatment. Maxillofac Plast Reconstr Surg 38:5. https://doi.org/10.1186/s40902-016-0051-7. eCollection 2016 Dec.
  3. Meunier FA, Schiavo G, Molgo J (2002) Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular transmission. J Physiol Paris 96(1-2):105-113 https://doi.org/10.1016/S0928-4257(01)00086-9
  4. Bhidayasiri R, Truong DD (2005) Expanding use of botulinum toxin. J Neurol Sci 235(1-2):1-9 https://doi.org/10.1016/j.jns.2005.04.017
  5. Qerama E, Fuglsang-Frederiksen A, Jensen TS (2010) The role of botulinum toxin in management of pain: an evidence-based review. Curr Opin Anaesthesiol 23:602-610 https://doi.org/10.1097/ACO.0b013e32833c3405
  6. Qerama E, Fuglsang-Frederiksen A, Kasch H, Bach FW, Jensen TS (2006) A doubleblind, controlled study of botulinum toxin A in chronic myofascial pain. Neurology 67:241-245 https://doi.org/10.1212/01.wnl.0000224731.06168.df
  7. List T, Axelsson S, Leijon G (2003) Pharmacologic interventions in the treatment of temporomandibular disorders, atypical facial pain, and burning mouth syndrome. A qualitative systematic review. J Orofac Pain 17(4):301-310
  8. Zakrzewska JM (2013) Differential diagnosis of facial pain and guidelines for management. Br J of Anaesth 111(1):95-104 https://doi.org/10.1093/bja/aet125
  9. Melis M, Di Giosia M, Zawawi KH (2012) Low level laser therapy for the treatment of temporomandibular disorders: a systematic review of the literature. Cranio 30(4):304-312 https://doi.org/10.1179/crn.2012.045
  10. Petrucci A, Sgolastra F, Gatto R, Mattei A, Monaco A (2011) Effectiveness of low-level laser therapy in temporomandibular disorders: a systematic review and meta-analysis. J Orofac Pain 25(4):298-308
  11. Yang HW, Huang YF (2011) Treatment of persistent idiopathic facial pain (PIFP) with a low-level energy diode laser. Photomed Laser Surg 29(10):707-710 https://doi.org/10.1089/pho.2011.3030
  12. Freund B, Schwartz M (1998) The use of botulinum toxin for the treatment of temporomandibular disorder: a pilot study. Oral Health 88:32-37
  13. Freund B, Schwartz M, Symington JM (1999) The use of botulinum toxin for the treatment of temporomandibular disorders: preliminary findings. J Oral Maxillofac Surg 57:916-920 https://doi.org/10.1016/S0278-2391(99)90007-1
  14. Gooriah R, Ahmed F (2015) Therapeutic uses of botulinum toxin. J Clin Toxicol 5:1
  15. Glenn T (2007) A critical review of the use of botulinum toxin in orofacial pain disorders. Dent Clin N Am 51:245-261 https://doi.org/10.1016/j.cden.2006.09.003
  16. Thomas (2016) The efficacy of botulinum toxin for the treatment of trigeminal and postherpetic neuralgia: a systematic review with metaanalyses. Oral Surg Oral Med Oral Pathol Oral Radiol 122:61-71 https://doi.org/10.1016/j.oooo.2016.03.003
  17. Francesco (2016) Conversion ratio between $Botox^{(R)}$, $Dysport^{(R)}$, and $Xeomin^{(R)}$ in clinical practice. Toxins 8:65 https://doi.org/10.3390/toxins8030065
  18. Won CH (2013) Efficacy and safety of a novel botulinum toxin type a product for the treatment of moderate to severe glabellar lines: a randomized, double-blind, active-controlled multicenter study. Dermatol Surg 39:171-178 https://doi.org/10.1111/dsu.12072

Cited by

  1. Botulinum Toxin Injection to Treat Masticatory Movement Disorder Corrected Mandibular Asymmetry in a Growing Patient : vol.30, pp.6, 2018, https://doi.org/10.1097/scs.0000000000005606
  2. Pain complications of oral implants: Is that an issue? vol.48, pp.2, 2018, https://doi.org/10.1111/joor.13112